Skip to main content
. 2024 Aug 6;73(10):205. doi: 10.1007/s00262-024-03790-7

Fig. 2.

Fig. 2

Response and time-on-treatment arranged by cohort; all treated analysis set. AE adverse events, d/c discontinuation, PD progressive disease, SD stable disease